Fact CheckerSign in

NCT06298617Completed

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis: A Comparative Study Versus Exploratory Laparoscopy

Source: ClinicalTrials.gov · Last updated 12 Mar 2024

Brief summary (registry, in English)

Endometriosis (EMs) is one of the commonest chronic inflammatory disorder affecting women and is characterized by the presence and growth of endometrial-like glandular epithelial and stromal cells outside the uterus leading to multiple clinical symptoms affecting patients quality of life and fertility with high recurrence rate . The systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) are documented as prognostic serum biomarker in many kinds of cancer and for the need and outcomes of adjuvant therapies for various cancers .

Status (registry)
Completed
Study type
Observational
Enrollment
88 (actual)
First submitted
1 Mar 2024
Start date
1 Jan 2023
Primary completion date
30 Jul 2023
Lead sponsor
Benha University
NCT number
NCT06298617

What you commit to

  • Study type: Observational
  • Participants enrolled: 88
  • From 1 Jan 2023 to the primary completion date, 30 Jul 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Women with cancer elsewhere in the body or receiving adjuvant therapies for cancer;
  • Patients receiving therapies for viral disorders especially COVID;

Other illness

  • Patients had autoimmune diseases, maintained on immunosuppressive therapy for any indication;

Other

  • Women with EM and were maintained on treatment or underwent operative interference during the last three months;
  • Patients refusing to undergo the exploratory laparoscopy.

Who the study is looking for

  • Women with clinical manifestations suggestive of having EM;
  • Women who was professionally diagnosed;
  • Women who was diagnosed by radiologic workup;
  • Women were free of exclusion criteria.

Age in the registry: 25 years to 50 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Benha University
Coordinator of this site? Confirm its status
BanhāEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.